Streszczenie
3/2021
vol. 16
Artykuł oryginalny
Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
- Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Diseases Unit, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland
- Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland
- Faculty of Medicine and Health Science, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev 2021; 16 (3): 207–212
Data publikacji online: 2020/11/12
Dostępne w
Zintergrowane z


